GlobeNewswire by notified

Amlan® International to Present Innovative Mineral Technology Solutions at VIV Asia 2023

Share
  • Annually one-third of the world’s broiler meat is supplied by Asia, making this region critical to the global food supply.
  • VIV Asia attendees can meet with Amlan technical experts and the local sales team to learn more about their innovative mineral-based products at booth 3650.
  • Amlan will host two presentations on natural alternatives to promote animal health and improve production efficiencies at the VIV Asia 2023 global trade show.
  • Dr. Aldo Rossi will present features of recently launched Phylox® (available in select international markets), a natural alternative to anticoccidial drugs that improves gut health and production efficiencies.
  • Dr. Marc Herpfer will present Calibrin®-Z (available in select international markets) research and discuss the capabilities of advanced mineral technology for biotoxin control.

CHICAGO, March 01, 2023 (GLOBE NEWSWIRE) -- Amlan® International, the animal health business of Oil-Dri® Corporation of America and a global leader in natural, mineral-based feed additives for poultry and livestock, will provide producers in the Asia-Pacific region with an opportunity to learn about research-backed solutions that optimize gut health and improve economic production at the upcoming VIV Asia 2023 conference to be held at the IMPACT venue, March 8-10, 2023, in Bangkok, Thailand. The conference, which features more than 200 professional speakers and more than 45,000 visitors, offers an opportunity for producers and companies like Amlan to connect at the largest feed-to-food global trade show in Asia. 

Asia supplied 36% of the world’s demand for broiler meat, producing 44 million metric tons in 2020. Poultry producers in India, Indonesia and Japan are leading broiler meat production in the Asian region, with Vietnam and Pakistan showing rapid growth in the last five years.

Additionally, almost one-half of annual global swine production and over 30% of the world’s milk production is from Asia. 

Recognizing Asia's impact on the global food supply, Amlan has built a robust sales and technical service team throughout the region. During the conference, producers can visit Amlan experts at booth 3650 where they will showcase their full range of feed additives, including Phylox®, Calibrin®-Z and Varium® (all available in select international markets), which promote optimal intestinal health and feed efficiency, adding value for producers by maximizing poultry and livestock performance. 

“Our mineral-based products protect poultry and livestock health by binding bacterial toxins and mycotoxins. We are excited to be presenting to this vital international audience,” said Dr. Saksake Pacharadit, Regional Sales Manager for the Asia-Pacific Region. “Unlike other clay-based products, Amlan selects our single-source mineral and leverages a proprietary thermal processing technique (not harsh chemicals), tailored specifically for each of our products, to optimize product efficacy. We’re pleased to be showcasing our products in such an important market like Thailand where the production of broiler and pork meat ranks among the top five for the Asia-Pacific region.” 

Amlan will also host two informative presentations during VIV Asia. The first, to be held at 11 a.m. on Wednesday, March 8, will be presented by Dr. Marc Herpfer, Vice President of New Technologies, Oil-Dri® Corporation of America, who will discuss “Natural Mineral Technology for Advanced Biotoxin Control.” At 11 a.m. on Thursday, March 9, Dr. Aldo Rossi, Vice President, Innovation and Technical Service, Amlan International, will present on “Natural Alternatives for Controlling Coccidiosis.” 

“During VIV Asia, attendees will get acquainted with Amlan’s innovative and intelligent feed additive solutions through two presentations by Amlan experts,” said Dr. Wade Robey, Vice President of Agriculture, Oil-Dri Corporation of America, and President, Amlan International. “Coccidiosis and performance challenges affect poultry production costing the global chicken industry billions every year. Our products, Calibrin-Z and Phylox, support gut health, improve productivity, and help drive producers' profits.”

For more information about Phylox, Calibrin-Z, Varium or Amlan’s full portfolio of products, visit www.amlan.com.

Company Information

Amlan is the animal health business of Oil-Dri Corporation of America, a leading global manufacturer and marketer of sorbent minerals. Oil-Dri leverages over 80 years of expertise in mineral science to selectively mine and process their unique mineral for consumer and business-to-business markets. Oil-Dri Corporation of America doing business as “Amlan International” is a publicly traded stock on the New York Stock Exchange (NYSE: ODC). Amlan International sells feed additives across the world. Product availability may vary by country, associated claims do not constitute medical claims and may differ based on government requirements.

Reagan Culbertson
Media Contact
press@amlan.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/8dc742dc-e446-459b-9280-bec32c356e77

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Updated financial calendar for 202425.4.2024 16:00:00 CEST | Press release

Company announcement no 7-2024 Søborg April, 25, 2026 Updated financial calendar for 2024 Konsolidator A/S (“Konsolidator”) has decided to advance the publication of the Q1 2024 report to April 26, 2024, instead of May 8, 2024, as previously announced. The financial calendar has been updated accordingly: April 26, 2024: Q1 2024 ReportAugust 22, 2024: Q2 2024 ReportNovember 7, 2024: Q3 2024 Report The advanced publication of the Q1 2024 Report is due to a wish of ending the current blackout period (the closed trading window) for the board of directors and management. Konsolidator has received positive interest from private investors, including all members of the board of directors, to inject additional capital in a possible directed issue of new shares. By ending the blackout period, the board of directors will be able to participate in a possible directed issue of new shares. The Q1 2024 Report is published in the morning April 26, 2024 followed by an investor presentation at April 30,

Notice of IDEX Biometrics 2024 annual general meeting on 16 May 202425.4.2024 16:00:00 CEST | Press release

IDEX Biometrics ASA will hold its 2024 annual general meeting on Thursday 16 May 2024 at 12.00 hours CET as an online meeting. There is no physical attendance option. Shareholders may attend online. by PC, smartphone or tablet. The notice with attendance form will be sent to the shareholders today and is also enclosed in pdf file (link below). The notice of the annual general meeting and the ancillary documents are/will be available at the company's web site, www.idexbiometrics.com, and can be requested from the company at no charge from ir@idexbiometrics.com . The Nomination Committee's recommendation will be disclosed later. For further information contact: Marianne Bøe, Head of investor relations E-mail: marianne.boe@idexbiometrics.com Tel: +47 918 00186 About IDEX Biometrics IDEX Biometrics ASA (OSE: IDEX) is a global technology leader in fingerprint biometrics, offering authentication solutions across payments, access control, and digital identity. Our solutions bring convenience,

Decisions of Sampo plc’s Annual General Meeting25.4.2024 15:35:00 CEST | Press release

SAMPO PLC DECISIONS OF GENERAL MEETING 25 April 2024 at 4:35 pm Decisions of Sampo plc’s Annual General Meeting The Annual General Meeting of Sampo plc, held today on 25 April 2024, approved all the proposals made to the AGM by the Board of Directors and its Committees, including distribution of dividend of EUR 1.80 per share for 2023. The AGM adopted the financial accounts for 2023 and discharged the members of the Board of Directors and CEO from liability for the financial year ending 31 December 2023. The AGM authorised the Board of Directors to decide on share repurchases and a share issue without payment. Including proxy representatives, there were altogether 320,218,518 shares (63.8 per cent of shares) and 321,018,518 votes (63.9 per cent of all votes) in the company represented at the Annual General Meeting. Dividend payment The AGM decided to distribute a dividend of EUR 1.80 per share for 2023. The dividend will be paid to the shareholders registered in the Company’s sharehold

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)25.4.2024 15:30:00 CEST | Press release

ORION CORPORATION STOCK EXCHANGE RELEASE – MAJOR SHAREHOLDER ANNOUNCEMENTS 25 APRIL 2024 at 16.30 EEST Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) Orion Corporation has received a disclosure under Chapter 9, Section 5 of the Securities Market Act, according to which the total number of Orion shares owned directly, indirectly and through financial instruments by BlackRock, Inc. and its funds increased on 24 April 2024 above five (5) per cent of Orion Corporation’s total shares. Total positions of BlackRock, Inc. and its funds subject to notification: % of shares and voting rights (total of point A)% of shares and voting rights through financial instruments (total of point B)Total of both in % (points A + B)Total number of shares and voting rights of issuerResulting situation on the date on which threshold was crossed or reached4.99% shares Below 5% voting rights0.02% shares Below 5% voting rights5.01% shares Below 5% voting rig

HiddenA line styled icon from Orion Icon Library.Eye